The regulatory effect of ginsenoside Rg3 on expression of somatostatin receptor in lung carcinoma allografts in mice and its significance

Tumor

Volumn 32, Issue 8, 2012, Pages 572-577

  He, Jian Bin ^a   Liao, Hui Zhong ^a   Yi, Gao Zhong ^a   Chen, Zhi Kui ^a   He, Wei ^a  

^a Department of Respiratory Diseases   (China)

Author keywords

Ginsenoside Rg3; Lung neoplasms; Neoplasm metastasis; Receptors, somatostatin

Indexed keywords

ANTINEOPLASTIC AGENT; CELL NUCLEUS ANTIGEN; CISPLATIN; GINSENOSIDE RG 3; PROLIFERATION CELL NUCLEAR ANTIGEN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LEWIS CARCINOMA; METASTASIS; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 84865784299     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2012.08.002     Document Type: Article

References (4)

1. KRZAKOWSKI M. New agent s wi thin the preoperative chemotherapy of non-small cell lung cancer[J]. Lung Cancer, 2001, 34(Suppl 2): S159-163. (Pubitemid 33101861)
2. HARRIS J E, THUN M J, MONDUL A M, et al. Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8[J]. BMJ, 2004, 328(7431):72.
3. MITSOGIANNIS I C, SKOLARIKOS A, DELIVELIOTIS C. Somatostatin analog lanreotide in the treatment of castration resistant prostate cancer (CRPC)[J]. Expert Opin Pharmacother, 2009, 10(3):493-501.
4. KO Y H, JUNG C K, LEE M A, et al. Clinical significance of vascular endothelial growth factors (VEGF) -C and -D in resected non-small cell lung cancer[J]. Cancer Res Treat, 2008, 40(3):133-140.